首页> 外文期刊>Cancer Medicine >Targeted next-generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families
【24h】

Targeted next-generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families

机译:22种错配修复基因的靶向下一代测序可鉴定Lynch综合征家族

获取原文
获取外文期刊封面目录资料

摘要

Abstract Causative germline mutations in mismatch repair (MMR) genes can only be identified in ~50% of families with a clinical diagnosis of the inherited colorectal cancer (CRC) syndrome hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome (LS). Identification of these patients are critical as they are at substantially increased risk of developing multiple primary tumors, mainly colorectal and endometrial cancer (EC), occurring at a young age. This demonstrates the need to develop new and/or more thorough mutation detection approaches. Next-generation sequencing (NGS) was used to screen 22 genes involved in the DNA MMR pathway in constitutional DNA from 14 HNPCC and 12 sporadic EC patients, plus 2 positive controls. Several softwares were used for analysis and functional annotation. We identified 5 exonic indel variants, 42 exonic nonsynonymous single-nucleotide variants (SNVs) and 1 intronic variant of significance. Three of these variants were class 5 (pathogenic) or class 4 (likely pathogenic), 5 were class 3 (uncertain clinical relevance) and 40 were classified as variants of unknown clinical significance. In conclusion, we have identified two LS families from the sporadic EC patients, one without a family history of cancer, supporting the notion for universal MMR screening of EC patients. In addition, we have detected three novel class 3 variants in EC cases. We have, in addition discovered a polygenic interaction which is the most likely cause of cancer development in a HNPCC patient that could explain previous inconsistent results reported on an intronic EXO1 variant.
机译:摘要错配修复(MMR)基因的致病种系突变只能在约50%具有遗传性大肠癌(CRC)综合征遗传性非息肉病大肠癌(HNPCC)/ Lynch综合征(LS)临床诊断的家庭中鉴定。对这些患者的鉴定至关重要,因为他们患幼年出现多种原发性肿瘤的风险显着增加,主要是结直肠癌和子宫内膜癌(EC)。这表明需要开发新的和/或更彻底的突变检测方法。下一代测序(NGS)用于筛选来自14例HNPCC和12例散发EC患者以及2例阳性对照的体质DNA中涉及DNA MMR途径的22个基因。一些软件用于分析和功能注释。我们确定了5个外显子indel变异体,42个外显子非同义单核苷酸变异体(SNV)和1个内含子显着性变异。这些变体中的三个是5类(致病性)或4类(可能是致病性的),5个是3类(不确定的临床相关性),另外40个被归类为临床意义未知的变体。总之,我们从散发性EC患者中鉴定出两个LS家庭,一个没有癌症家族史,支持对EC患者进行普遍MMR筛查的观点。此外,我们在EC病例中检测到三个新颖的3类变异。此外,我们还发现了一种多基因相互作用,这是HNPCC患者最可能导致癌症发展的原因,这可以解释以前关于内含子EXO1变异体报道的不一致结果。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号